Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,957 million for the third quarter of 2014, a 19 percent increase from the same period in 2013. Third quarter total revenue increased 18 percent to $1,982 million compared to $1,674 million in the third quarter of 2013. Adjusted net income for the third quarter of 2014 increased 20 percent to $806 million compared to $669 million in the third quarter of 2013. For the same period, adjusted diluted earnings per share (EPS) increased 24 percent to $0.97 from $0.78, on a stock split-adjusted basis.
Help employers find you! Check out all the jobs and post your resume.
